C
IRWD icon

Covestor’s Ironwood Pharmaceuticals IRWD Stock Holding History

Covestor’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$0 Buy
95
+1
+1% +$4 ﹤0.01% 2516
2025
Q4 		$0 Hold
94
– – ﹤0.01% 2491
2025
Q3 		$0 Hold
94
– – ﹤0.01% 2508
2025
Q2 		$0 Buy
94
+77
+453% +$60 ﹤0.01% 2461
2025
Q1 		$0 Hold
17
– – ﹤0.01% 2467
2024
Q4 		$0 Buy
17
+1
+6% +$4 ﹤0.01% 2476
2024
Q3 		$0 Buy
16
+6
+60% +$32 ﹤0.01% 2457
2024
Q2 		$0 Hold
10
– – ﹤0.01% 2476
2024
Q1 		$0 Sell
10
-4
-29% -$49 ﹤0.01% 2475
2023
Q4 		$0 Sell
14
-907
-98% -$8.97K ﹤0.01% 2399
2023
Q3 		$9K Buy
921
+71
+8% +$696 0.01% 1484
2023
Q2 		$9K Buy
850
+489
+135% +$5.26K 0.01% 1508
2023
Q1 		$4K Buy
361
+14
+4% +$157 ﹤0.01% 1608
2022
Q4 		$4K Sell
347
-108
-24% -$1.23K ﹤0.01% 1626
2022
Q3 		$5K Sell
455
-67
-13% -$760 ﹤0.01% 1493
2022
Q2 		$6K Sell
522
-28
-5% -$330 ﹤0.01% 1362
2022
Q1 		$7K Buy
550
+228
+71% +$2.61K ﹤0.01% 1408
2021
Q4 		$4K Buy
+322
New +$3.95K 0.01% 1396

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Covestor's IRWD Position: Q1 2026 in Review

Covestor increased its Ironwood Pharmaceuticals (IRWD) stake by 1.1% in Q1 2026, buying an estimated $4 and bringing the position to 95 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2516.

Covestor first reported a position in IRWD in Q4 2021 and has held it in 18 quarters since. The position peaked at $9K in Q3 2023. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Covestor held 95 shares of Ironwood Pharmaceuticals worth $0 as of Q1 2026.
  • Covestor bought 1 Ironwood Pharmaceuticals share in Q1 2026, an estimated $4.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Covestor's portfolio in Q1 2026, its #2516 holding.
  • Covestor first reported a position in Ironwood Pharmaceuticals in Q4 2021 and has held it in 18 quarters since.
  • Covestor's Ironwood Pharmaceuticals position peaked at $9K in Q3 2023.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Covestor's 13F filing for Q1 2026, filed 5 May 2026.